Conference Coverage
NewsNetwork
OncLive TV
PEER EXCHANGE
OncLive INSIGHTS

PER is hosting the 2nd Annual International Congress on Oncology Pathology™ | June 23rd in NYCHematologic Malignancies Medical Crossfire in NYC on July 14th! Register today!

SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Neoadjuvant HER2+
More >>
<< View all publications

Contemporary Radiation Oncology

Combined Radiation Therapy and Checkpoint Inhibition in Lymphoma: A Case Report and Brief Review
Combined Radiation Therapy and Checkpoint Inhibition in Lymphoma: A Case Report and Brief Review
Biomarkers, Pathways, and Targeted Therapies.®">March 2018
Biomarkers, Pathways, and Targeted Therapies.®   >   Feature
Phase II Clinical Trial of Intratumoral Dendritic Cells Injections and Neoadjuvant Radiotherapy in Resectable Soft Tissue Sarcomas
Phase II Clinical Trial of Intratumoral Dendritic Cells Injections and Neoadjuvant Radiotherapy in Resectable Soft Tissue Sarcomas
August 2017   >   Feature
Radiation Therapy, Chemotherapy, Targeted Therapy, and Possibly Immunotherapy in Localized Sarcoma
Radiation Therapy, Chemotherapy, Targeted Therapy, and Possibly Immunotherapy in Localized Sarcoma
July 2017   >   Feature
Modeling T-Cell Trafficking to Increase the Likelihood of Radiation-Induced Abscopal Effects
Modeling T-Cell Trafficking to Increase the Likelihood of Radiation-Induced Abscopal Effects
April 2017   >   Articles
A Comprehensive Review of Hemibody Irradiation for Patients with Bone Metastases
A Comprehensive Review of Hemibody Irradiation for Patients with Bone Metastases
July 2017   >   Feature
PrimeMD, a Pain Reporting Smartphone Application for Patients Undergoing Head and Neck Radiation
PrimeMD, a Pain Reporting Smartphone Application for Patients Undergoing Head and Neck Radiation
April 2017   >   Feature
Radiation for Chemo-Sensitization: A Phase II Trial of Cetuximab and Docetaxel With Low-Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma
Radiation for Chemo-Sensitization: A Phase II Trial of Cetuximab and Docetaxel With Low-Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma
September 2016   >   Feature
Radiotherapy in the Modern Era in the Management of Langerhans Cell Histiocytosis
Radiotherapy in the Modern Era in the Management of Langerhans Cell Histiocytosis
September 2016   >   Articles
Factors Influencing Patient-Reported Rectal Toxicity Following External Beam Radiation Therapy for Prostate Cancer
Factors Influencing Patient-Reported Rectal Toxicity Following External Beam Radiation Therapy for Prostate Cancer
September 2016   >   Feature
Radiation Dose Escalation to the Tumor-Arterial Interface of Locally Advanced and Borderline Resectable Pancreatic Cancer
Radiation Dose Escalation to the Tumor-Arterial Interface of Locally Advanced and Borderline Resectable Pancreatic Cancer
June 2016   >   Articles
Next Page >>
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
Publication Bottom Border
Border Publication
 
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.
 
x